Hims & Hers Health Inc (NYSE: HIMS) is 53.18% higher on its value in year-to-date trading and has touched a low of $11.20 and a high of $72.98 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HIMS stock was last observed hovering at around $37.41 in the last trading session, with the day’s loss setting it -0.37%.
Currently trading at $37.04, the stock is 1.39% and -4.89% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 17.47 million and changing -0.99% at the moment leaves the stock 42.61% off its SMA200. HIMS registered 121.40% gain for a year compared to 6-month gain of 127.24%. The firm has a 50-day simple moving average (SMA 50) of $38.9456 and a 200-day simple moving average (SMA200) of $25.97305.
The stock witnessed a -27.81% loss in the last 1 month and extending the period to 3 months gives it a 40.52%, and is 17.62% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.28% over the week and 11.41% over the month.
Hims & Hers Health Inc (HIMS) has around 1637 employees, a market worth around $8.23B and $1.48B in sales. Current P/E ratio is 69.26 and Fwd P/E is 43.07. Profit margin for the company is 8.54%. Distance from 52-week low is 230.71% and -49.25% from its 52-week high. The company has generated returns on investments over the last 12 months (25.92%).
with sales reaching $535.21M over the same period.The EPS is expected to grow by 12.77% this year, but quarterly earnings will post 57.93% year-over-year. Quarterly sales are estimated to grow 92.40% in year-over-year returns.
Hims & Hers Health Inc (HIMS) Top Institutional Holders
536.0 institutions hold shares in Hims & Hers Health Inc (HIMS), with institutional investors hold 89.11% of the company’s shares. The shares outstanding are 212.46M, and float is at 181.97M with Short Float at 28.49%. Institutions hold 79.06% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 16.47 million shares valued at $332.55 million. The investor’s holdings represent 7.7166% of the HIMS Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 14.57 million shares valued at $294.25 million to account for 6.7907 of the shares outstanding. The other top investors are RENAISSANCE TECHNOLOGIES LLC which holds 6.04 million shares representing 2.8294% and valued at over $121.94 million, while holds 2.4507 of the shares totaling 5.26 million with a market value of $106.19 million.
Hims & Hers Health Inc (HIMS) Insider Activity
The most recent transaction is an insider sale by Okupe Oluyemi, the company’s Chief Financial Officer. SEC filings show that Okupe Oluyemi sold 23,118 shares of the company’s common stock on Mar 21 ’25 at a price of $32.41 per share for a total of $0.75 million. Following the sale, the insider now owns 0.13 million shares.
Still, SEC filings show that on Mar 18 ’25, Carroll Patrick Harrison (Chief Medical Officer) disposed off 23,287 shares at an average price of $34.31 for $0.8 million. The insider now directly holds 209,661 shares of Hims & Hers Health Inc (HIMS).
